SCHEMBL500281

SCHEMBL500281

O=CC1(Br)CC=Cc2ccccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3729652 0.75 HDAC4 (0.33)
SCHEMBL9663013 0.75 HTR2A (0.31)
SCHEMBL9436076 0.75 OXTR (0.30)
SCHEMBL3209428 0.72 HDAC4 (0.31)
SCHEMBL31693139 0.72
SCHEMBL2800949 0.72 KDM4E (0.34)
SCHEMBL31186268 0.72 KDM4E (0.34)
SCHEMBL11696235 0.71 POLB (0.30)
SCHEMBL8489491 0.70 THRB (0.35)
SCHEMBL30897428 0.70 GAA (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106031-B2 Hydrolytically-resistant boron-containing therapeutics and methods of use ANACOR PHARMACEUTICALS, INC. (US) 2012-01-31 US disclosed
EP-2066789-A2 CRYSTAL STRUCTURE OF A TRNA SYNTHETASE Anacor Pharmaceuticals, Inc. (US) 2009-06-10 EP disclosed
EP-2044091-A2 COMPOUNDS FOR THE TREATMENT OF PERIODONTAL DISEASE Anacor Pharmaceuticals, Inc. (US) 2009-04-08 EP disclosed
EP-2015757-A2 HYDROLYTICALLY-RESISTANT BORON-CONTAINING THERAPEUTICS AND METHODS OF USE Anacor Pharmaceuticals, Inc. (US) 2009-01-21 EP disclosed
WO-2008070257-A9 CRYSTAL STRUCTURE OF A TRNA SYNTHETASE ANACOR PHARMACEUTICALS INC (US) 2008-09-04 WO disclosed
WO-2008070257-A2 CRYSTAL STRUCTURE OF A TRNA SYNTHETASE ANACOR PHARMACEUTICALS, INC. (US) 2008-06-12 WO disclosed
WO-2007146965-A2 COMPOUNDS FOR THE TREATMENT OF PERIODONTAL DISEASE ANACOR PHARMACEUTICALS, INC. (US) 2007-12-21 WO disclosed
US-20070286822-A1 Compounds for the Treatment of Periodontal Disease ANACOR PHARMACEUTICALS INC. (US) 2007-12-13 US disclosed
WO-2007131072-A2 HYDROLYTICALLY-RESISTANT BORON-CONTAINING THERAPEUTICS AND METHODS OF USE ANACOR PHARMACEUTICALS, INC. (US) 2007-11-15 WO disclosed
US-20070265226-A1 Hydrolytically-Resistant Boron-Containing Therapeutics And Methods Of Use ANACOR PHARMACEUTICALS (US) 2007-11-15 US disclosed